Solvonis Therapeutics (SVNS)

Sector:

Pharma and Biotech

0.24p
   
  • Change Today:
      0.001p
  • 52 Week High: 0.39
  • 52 Week Low: 0.13
  • Currency: UK Pounds
  • Shares Issued: 6,806m
  • Volume: 775,096
  • Market Cap: £16.43m
  • Beta: 0.02

Regulatory News

Final Results 29-Apr-2026 07:00 RNS
Granted U.S. Patent from PTSD Discovery Programme 08-Apr-2026 07:00 RNS
Granted U.S. Patent from PTSD Discovery Programme 31-Mar-2026 07:00 RNS
SVN-114 selected for PTSD discovery programme 10-Mar-2026 07:00 RNS
SVN-114 selected for PTSD discovery programme 10-Mar-2026 07:00 RNS
Expansion of SVN-015 into depression 28-Jan-2026 07:00 RNS
US Patent allowance for PTSD discovery programme 07-Jan-2026 07:00 RNS
Research and Development Update – Q4 2025 22-Dec-2025 07:00 RNS
Research and Development Update – Q4 2025 22-Dec-2025 07:00 RNS
SVN-015 accepted into US NIDA funded programme 03-Dec-2025 07:00 RNS
Appoints global biopharma leader Paul Carter 27-Oct-2025 07:00 RNS
Raises £1.25 Million to Accelerate Programmes 16-Oct-2025 07:00 RNS
Half-year Report 30-Sep-2025 07:00 RNS
Solvonis secures exclusive CNS collaboration 28-Aug-2025 07:00 RNS
SVN-SDN-14 PTSD - Positive pre-clinical results 12-Aug-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SVNS Market Data

Currency UK Pounds
Share Price 0.24p
Change Today 0.001p
% Change 0.60 %
52 Week High 0.39
52 Week Low 0.13
Volume 775,096
Shares Issued 6,806m
Market Cap £16.43m
Beta 0.02

SVNS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average44.84% below the market average
2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average2.44% above the sector average
Price Trend
35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average35.55% above the market average
40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average40.91% above the sector average
Income Not Available
Growth Not Available

SVNS Dividends

No dividends found

Trades for 11-May-2026

Time Volume / Share Price
08:18 81,967 @ 0.24p
08:07 100,340 @ 0.24p
08:05 12,789 @ 0.24p
08:01 580,000 @ 0.24p

SVNS Key Personnel

CEO Anthony Tennyson
Chair Dennis Purcell

Top of Page